Assembly Biosciences ASMB
NASDAQ ASMB
$22.54 -0.44 (-1.91%)
At close: Oct 2, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Non Operating Investment Income (2015 - 2016)

Updated

Assembly Biosciences (ASMB) recorded Non Operating Investment Income of -$615,000 in FY2017, compared with -$1.14 million in FY2016.

Analysis

Assembly Biosciences (ASMB) Non Operating Investment Income (2015 - 2016) Analysis & Trends

  • Per Business Quant data, ASMB's Non Operating Investment Income was -$1.14 million in FY2016 and -$821,585 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Assembly Biosciences 447.43 Mn -580.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 72,090.00
Dec 31, 2015 -433,707.00
Sep 30, 2015 -253,659.00
Jun 30, 2015 -134,219.00
API Access

Assembly Biosciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ASMB&period=max&api_key=YOUR_API_KEY